Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Erythropoiesis01:14

Erythropoiesis

3.9K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The NanoBridge system for targeted post-translational modification of challenging proteins.

bioRxiv : the preprint server for biology·2026
Same author

Explainable AI reveals squamous histology and U-shaped PD-L1 patterns as primary subgroup predictors of neoadjuvant and perioperative immunotherapy benefit in NSCLC: a machine learning analysis.

Cancer immunology, immunotherapy : CII·2026
Same author

Explosive cytotoxicity of ruptoblasts bridges hormone surveillance and immune defense.

Cell·2026
Same author

Capsule modulation enhances immunity and delays resistance in MDR <i>Acinetobacter baumannii</i>.

iScience·2026
Same author

Meta-analysis of cutaneous immune-related adverse events in NSCLC: Accounting for treatment heterogeneity and immortal time bias.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Equivalence of neoadjuvant and perioperative therapies in patients with stage III non-small cell lung cancer: a systematic review and meta-analysis.

Journal of thoracic disease·2026

Related Experiment Video

Updated: May 10, 2025

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.3K

Engineering Cell-Specific Protein Delivery Vehicles for Erythroid Lineage Cells.

Mekedlawit T Setegne1,2, Aidan T Cabral3, Anushri Tiwari4

  • 1Department of Chemistry, Stanford University, Stanford, California 94305, United States.

ACS Bio & Med Chem Au
|April 21, 2025
PubMed
Summary

Delivering biologics into challenging erythroid cells requires advanced methods. This study evaluates cell penetrating peptides and receptor targeting to improve protein delivery efficiency and specificity for therapeutic applications.

More Related Videos

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.1K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

383

Related Experiment Videos

Last Updated: May 10, 2025

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors
11:46

Direct Lineage Reprogramming of Adult Mouse Fibroblast to Erythroid Progenitors

Published on: December 14, 2018

6.3K
Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
14:22

Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

Published on: July 16, 2011

13.1K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

383

Area of Science:

  • Biotechnology
  • Cell Biology
  • Drug Delivery

Background:

  • Biologics like proteins offer therapeutic potential but face delivery challenges due to poor membrane permeance, limiting intracellular applications.
  • Erythroid lineage cells present unique difficulties for cargo delivery owing to their distinct cytoskeleton and lack of endocytosis in mature forms.
  • Previous attempts using miniature proteins for bioPROTAC delivery to erythroid cells showed promise but suffered from low efficiency and specificity.

Purpose of the Study:

  • To comprehensively assess various delivery systems for cargo translocation into erythroid precursor cells.
  • To investigate the impact of targeting cell-surface receptors on the efficiency and specificity of these delivery vehicles.
  • To advance the understanding of protein delivery mechanisms into challenging cell types.

Main Methods:

  • Evaluation of cell penetrating peptides (CPPs), CPP additives, bacterial toxins, and contractile injection systems for cargo delivery.
  • Exploration of cell-surface receptor targeting strategies to enhance delivery to erythroid cells.
  • Comparative analysis of delivery vehicle performance with and without receptor-specific targeting.

Main Results:

  • Certain delivery vehicles demonstrated enhanced efficiency when targeted to specific cell surface receptors on erythroid precursor cells.
  • Other delivery systems did not show significant improvement through receptor-targeting strategies.
  • The study identified key factors influencing cargo delivery into difficult-to-transfect cell types.

Conclusions:

  • The findings provide critical insights into optimizing protein and biologic delivery to challenging cell types, particularly erythroid precursors.
  • Cell-surface receptor targeting can be a beneficial strategy for specific delivery vehicles, but its effectiveness varies.
  • This research contributes to the development of more effective intracellular biologic therapies by addressing delivery barriers.